Analytics for vaccine economics and pricing: insights and observations

References

• Plotkin SL, Plotkin SA. A short history of vaccination. Chap. 1 of Plotkin S, Orenstein W, Offit P, eds. Vaccines. 2012. 6 Saunders
   Google Scholar
• Whitney CG, Zhou F, Singleton J, Schuchat A. Benefits from immunization during the vaccines for children program era - United States, 1994-2013. MMWR Morb Mortal Wkly Rep 2014;63(16):352-5
   PubMed Web of Science ®Google Scholar
• Elam-Evans LD, Yankey D, et al. National, State, and Selected local area vaccination coverage among children aged 19-35 months- United States, 2013. MMWR Morb Mortal Wkly Rep 2014;63(34):741-8
   PubMed Web of Science ®Google Scholar
• Douglas RG, Samant VB. The vaccine industry. Chap. 3 of Plotkin S, Walter O, Paul O, editor. Vaccines. 2012. 6th edn Saunders
   Google Scholar
• Orenstein WA, Douglas RG, Rodewald LE, et al. Immunizations in the United States: success, structure, and stress - a complex collaboration involving government, industry, providers, academe, professional societies, and third-party payers. Health Aff 2005;24(3):599-610
   Web of Science ®Google Scholar
• Weniger BG, Chen RT, Jacobson SH, et al. Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. Vaccine 1998;16(19):1885-97
   PubMed Web of Science ®Google Scholar
• Jacobson SH. Vaccine pricing: how can we get it right? Expert Rev Vaccines 2012;11(10):1163-5
   PubMed Web of Science ®Google Scholar
• Cox MMJ, Onraedt A. Innovations in vaccine development: can regulatory authorities keep up? Expert Rev Vaccines 2012;11(10):1171-3
   PubMed Web of Science ®Google Scholar
• Kim JJ. The role of cost-effectiveness in US vaccination policy. N Engl J Med 2011;365(19):1760-1
   Google Scholar
• Centers for disease control and prevention. Advisory Committee on Immunization Practices (ACIP) Recommended immunization schedules for persons aged 0 through 18 years- United States, 2014. MMWR Morb Mortal Wkly Rep 2014;63(5):108-9
   Google Scholar
• Hamilton BE, Martin JA, Osterman MJK, Curtin SC. Births: Preliminary data for 2013. National vital statistics reports 2. National center for health statistics; Hyattsville, MD
   Google Scholar
• Centers for disease control and prevention. Vaccine price list (Contract ending 31 March 2015. Available from: www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html [Last accessed 23 July 2014]
   Google Scholar
• Food and drug administration. Vaccines licensed for immunization and distribution in the United States. [Accessed 3 September 2014]
   Google Scholar
• Lieu TA, Thompson KM, Prosser LA, et al. Emerging issues in vaccine economics: perspectives from the USA. Expert Rev Vaccines 2002;1(4):433-42
   PubMedGoogle Scholar
• Rappuoli R, Miller HI, Falkow S. The intangible value of vaccination. Science 2002;297(5583):937-9
   PubMed Web of Science ®Google Scholar
• Hinman AR. Financing vaccines in the 21st century: recommendations from the national vaccine advisory committee. Am J Prev Med 2005;29(1):71-5
   PubMed Web of Science ®Google Scholar
• Kaufmann JR, Miller R, Cheyne J. Vaccine supply chains need to be better funded and strengthened, or lives will be at risk. Health Aff 2011;30(6):1113-21
   PubMed Web of Science ®Google Scholar
• Offit PA. Why are pharmaceutical companies gradually abandoning vaccines? Health Aff 2005;24(3):622-30
   PubMed Web of Science ®Google Scholar
• Sloan FA, Berman S, Rosenbaum S, et al. The fragility of the US vaccine supply. N Engl J Med 2004;351:2443-7
   PubMed Web of Science ®Google Scholar
• Helfand C. Advair slide, China woes drop-kick Glaxo profits in Q1. http://www.fiercepharma.com/story/advair-slide-china-woes-drop-kick-glaxo-profits-q1/2014-04-30 [Accessed 27 October] 2014
   Google Scholar
• Centers for disease control and prevention. History of vaccine schedule. Available from: http://www.chop.edu/service/vaccine-education-center/vaccine-schedule/history-of-vaccine-schedule.html [Last] [accessed 23 July 2014]
   Google Scholar
• Centers for disease control and prevention. Combination vaccines for childhood immunization, recommendations of the Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), and American Academy of Family Physicians (AAFP). Morbidity and Mortality Weekly Report 1999;48(RR-4):1-15
   Google Scholar
• Kuppermann M, Nease RF, Ackerson LM, et al. Parents’ preferences for outcomes associated with childhood vaccinations. Pediatr Infect Dis J 2000;19(2):129
   Google Scholar
• LeBaron CW, Rodewald L, Humiston S. How much time is spent on well-child care and vaccinations? Arch Pediatr Adolesc Med 1999;153(11):1154
   Google Scholar
• Meyerhoff AS, Weniger BG, Jacobs RJ, et al. Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections. Pediatr Infect Dis J 2001;20(11):S57-62
   Google Scholar
• Pellissier JM, Coplan PM, Jackson LA, May JE. The effect of additional shots on the vaccine administration process: results of a time-motion study in 2 settings. Am J Manag Care 2000;6(9):1038
   PubMed Web of Science ®Google Scholar
• Mahmood K, Pelkowski S, Atherly D, et al. Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries. Hum Vaccin Immunother 2013;9(9):1894-902
   PubMed Web of Science ®Google Scholar
• Jacobson SH, Sewell EC, Deuson R, et al. An integer programming model for vaccine procurement and delivery for childhood immunization: a pilot study. Health Care Manage Sci 1999;2:1-9
   PubMedGoogle Scholar
• Glazner JE, Beaty B, Berman S. Cost of vaccine administration among pediatric practices. Pediatrics 2009;124(Suppl 5):S492-8
   Google Scholar
• Glazner JE, Beaty BL, Pearson KA, Berman S. The cost of giving childhood vaccinations: differences among provider types. Pediatrics 2004;113(6):1582-7
   Google Scholar
• Hall SN, Jacobson SH, Sewell EC. An analysis of pediatric vaccine formulary selection problems. Oper Res 2008;56(6):1348-65
   Web of Science ®Google Scholar
• Engineer FG, Keskinocak P, Pickering LK. Catch-up scheduling for childhood vaccination. Oper Res 2009;57(6):1307-19
   Web of Science ®Google Scholar
• Smalley HK, Keskinocak P, Engineer FG, et al. Universal tool for vaccine scheduling: applications for children and adults. Interfaces 2011;41(5):436-54
   Google Scholar
• Catch up immunization scheduler. Available from: www.vacscheduler.org/
   Google Scholar
• Behzad B, Jacobson SH, Jokela JA, Sewell EC. The relationship between pediatric combination vaccines and market effects. Am J Public Health 2014;104(6):998-1004
   Google Scholar
• Centers for disease control and prevention. Vaccines for children program. Available from: www.cdc.gov/vaccines/programs/vfc/about/vac-supply-policy/ [Last accessed 29 October 2014]
   Google Scholar
• Sewell EC, Jacobson SH, Weniger BG. Reverse engineering a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines. Pediatr Infect Dis J 2001;20(11):S45-56
   PubMed Web of Science ®Google Scholar
• Sewell EC, Jacobson SH. Using an integer programming model to determine the price of combination vaccines for childhood immunization. Ann Oper Res 2013;119:261-84
   Google Scholar
• Jacobson SH, Karnani T, Sewell EC. Analyzing the economic value of the hepatitis B-Haemophilus influenzae type b combination vaccine by reverse engineering a formulary selection algorithm. Vaccine 2003;21(17):2169-77
   Google Scholar
• Jacobson S, Sewell EC, Karnani T. Engineering the economic value of two pediatric combination vaccines. Health Care Manage Sci 2005;8(1):29-40
   PubMedGoogle Scholar
• Jacobson SH, Sewell EC. Using Monte Carlo Simulation to Deter- mine Combination Vaccine Price Distributions for Childhood Disease. Health Care Manag Sci 2002;5(2):135-45
   PubMedGoogle Scholar
• Robbins MJ, Jacobson SH, Sewell EC. Pricing strategies for combination pediatric vaccines and their impact on revenue: pediarix or Pentacel? Health Care Manag Sci 2010;13(1):54-64
   PubMed Web of Science ®Google Scholar
• Behzad B, Jacobson SH, Sewell EC. Pricing strategies for combination pediatric vaccines based on the lowest overall cost formulary. Expert Rev Vaccines 2012;11(10):1189-97
   PubMed Web of Science ®Google Scholar
• Robbins MJ, Jacobson SH, Shanbhag UV, Behzad B. The weighted set covering game: a vaccine pricing model for pediatric immunization. Informs J Comp 2014;26(1):183-98
   Web of Science ®Google Scholar
• Behzad B, Jacobson SH, Robbins MJ. A symmetric capacity-constrained differentiated oligopoly model for pediatric vaccine markets with linear demand. Tech report. University of Illinois; USA
   Google Scholar
• Lindley MC, Shen AK, Orenstein WA, et al. Financing the delivery of vaccines to children and adolescents: challenges to the current system. Pediatrics 2009;124(Suppl 5):S548-57
   Google Scholar
• Poland GA, Marcuse EK. Vaccine availability in the US: problems and solutions. Nat Immunol 2004;5(12):1195-8
   Google Scholar
• Ehreth J. The global value of vaccination. Vaccine 2003;21(7):596-600
   PubMed Web of Science ®Google Scholar
• Zhou F, Santoli J, Messonnier ML, et al. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Arch Pediatr Adolesc Med 2005;159(12):1136-44
   Google Scholar
• Zhou F, Shefer A, Wenger J, et al. Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics 2014;133(4):577-85
   PubMed Web of Science ®Google Scholar
• Postma MJ, Westra TA, Quilici S, Largeron N. Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples. Expert Rev Vaccines 2013;12(5):555-65
   PubMed Web of Science ®Google Scholar
• Meyerhoff AS, Greenberg DP, Jacobs RJ. Predicted effects of a new combination vaccine on childhood immunization coverage rates and vaccination activities. Dis Manag Health Outcomes 2005;13(5):317-26
   Google Scholar
• Berge JJ, Drennan DP, Jacobs RJ, et al. The cost of hepatitis a infections in American adolescents and adults in 1997. Hepatology 2000;31(2):469-73
   PubMed Web of Science ®Google Scholar
• Jacobs RJ, Greenberg DP, Koff RS, et al. Regional variation in the cost effectiveness of childhood hepatitis a immunization. Pediatr Infect Dis J 2003;22(10):904-14
   PubMed Web of Science ®Google Scholar
• Jacobs RJ, Meyerhoff AS, Zink T. Hepatitis a immunization strategies: universal versus targeted approaches. Clin Pediatr (Phila) 2005;44(8):705-9
   Google Scholar
• Chuck AW, Jacobs P, Tyrrell G, Kellner JD. Pharmacoeconomic evaluation of 10-and 13-valent pneumococcal conjugate vaccines. Vaccine 2010;28(33):5485-90
   PubMed Web of Science ®Google Scholar
• Newall AT, Reyes JF, Wood JG, et al. Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses. Vaccine 2014;32(7):759-65
   PubMed Web of Science ®Google Scholar
• Klein JO, Myers MG. Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions. Clin Infect Dis 2006;42(Suppl 3):S97-S103
   Google Scholar
• Shen AK, Rodewald LE, Birkhead GS. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States. Pediatrics 2009;124(Suppl 5):S540-7
   Google Scholar
• McGuire TG. Setting prices for new vaccines (in Advance). Int J Health Care Finance Econ 2003;3:207-24
   PubMedGoogle Scholar
• O’Leary ST, Allison MA, Lindley MC, et al. Vaccine financing from the perspective of primary care physicians. Pediatrics 2014;133(3):367-74
   Google Scholar
• Freed GL, Cowan AE, Clark SJ. Primary care physician perspectives on reimbursement for childhood immunizations. Pediatrics 2008;122(6):1319-24
   Google Scholar
• Shen AK, Sobczyk E, Simonsen L, et al. Financial impact to providers using pediatric combination vaccines. Pediatrics 2011;128(6):1087-93
   Google Scholar
• Gidengil CA, Rusinak D, et al. Financial barriers to implementing combination vaccines: perspectives from pediatricians and policy makers. Clin Pediatr (Phila) 2009;48(5):539-47
   Google Scholar
• Lieu TA, McGuire TG, Hinman AR. Overcoming economic barriers to the optimal use of vaccines. Health Aff 2005;24(3):666-79
   Web of Science ®Google Scholar
• Robbins MJ, Jacobson SH. Pediatric vaccine procurement policy: the monopsonist’s problem. Omega 2011;39(6):589-97
   Web of Science ®Google Scholar